Key result
Activation of KCa2 channels with NS309 (2 mg/kg) significantly reduced infarct volume from 69 mm³ to 45 mm³ and improved neurological function 24 hours after transient focal cerebral ischemia in mice.
Why the study?
Does activation of KCa2 channels prevent [Ca2+]i deregulation and reduce neuronal death following glutamate toxicity and cerebral ischemia?
Does activation of KCa2 channels prevent [Ca2+]i deregulation and reduce neuronal death following glutamate toxicity and cerebral ischemia?
Absolute Event Rate: 45% vs 69%
p-value: p=<0.05
Activation of KCa2 channels provides neuroprotection against excitotoxic neuronal cell death by preventing intracellular calcium deregulation.
May support KCa2 activation for neuroprotection in ischemia models; hypothesis-generating and should not change clinical practice.
Exacerbated activation of glutamate receptor-coupled calcium channels and subsequent increase in intracellular calcium ([Ca2+]i) are established hallmarks of neuronal cell death in acute and chronic neurological diseases. Here we show that pathological [Ca2+]i deregulation occurring after glutamate receptor stimulation is effectively modulated by small conductance calcium-activated potassium (KCa2) channels. We found that neuronal excitotoxicity was associated with a rapid downregulation of KCa2.2 channels within 3 h after the onset of glutamate exposure. Activation of KCa2 channels preserved KCa2 expression and significantly reduced pathological increases in [Ca2+]i providing robust neuroprotection in vitro and in vivo. These data suggest a critical role for KCa2 channels in excitotoxic neuronal cell death and propose their activation as potential therapeutic strategy for the treatment of acute and chronic neurodegenerative disorders.
No takes yet. Share an insight, caveat, or question.
Dolga et al. (2011) studied Glutamate excitotoxicity and cerebral ischemia. KCa2 channel activator NS309 vs. Vehicle control was evaluated on Infarct volume at 24 h after reperfusion (p=<0.05). Activation of KCa2 channels with NS309 (2 mg/kg) significantly reduced infarct volume from 69 mm³ to 45 mm³ and improved neurological function 24 hours after transient focal cerebral ischemia in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: